Computational Molecular Biology 2025, Vol.15, No.4, 183-192 http://bioscipublisher.com/index.php/cmb 189 staining was performed simultaneously to align the morphological structure. Then, the mrnas captured on the slides were sequenced, with each spatial point corresponding to a gene expression profile. The final result is data on thousands of spatial locations, ranging from the core of the tumor all the way to the surrounding microenvironment (Chew et al., 2021). The advantage of such a set of data lies in that it can not only examine gene expression but also preserve the spatial layout of the tissue, providing a relatively complete foundation for subsequent model analysis and biological interpretation (Janesick et al., 2022). 7.2 Modeling methods and parameter optimization This analysis employed a model that combines spatial clustering and graph convolutional networks, mainly aiming to examine the molecular characteristics of different regions in breast cancer tissues. Let's start with clustering. Not only do we group by gene expression, but also impose spatial location constraints to make the results appear continuous on the tissue sections rather than a bunch of scattered points. Next, treat each captured point as a node, connect adjacent points into edges, and form a spatial adjacency graph. Then, let GCN learn features on this graph and gradually delineate different regions (Hu et al., 2021). After the model started running, we repeatedly adjusted the number of clusters and parameters until the result stabilized. Finally, the slices were divided into several sections, each carrying its own "fingerprint" of gene expression, clearly revealing the spatial hierarchy of the tumor tissue (Long et al., 2023). 7.3 Biological interpretation and clinical significance of model results Judging from the model results, this breast cancer tissue is not a homogeneous pile of cells. The gene expression in the central region is the most active, especially those related to the cell cycle and proliferation, indicating that tumor cells proliferate rapidly here. But as you go further out, the situation changes - a large number of immune-related signals appear in the marginal area, with T-cell markers and inflammatory factors all piled up densely there (An et al., 2024). This distribution can also explain some common clinical phenomena. For instance, areas with more immune cells are more responsive to immunotherapy, while regions with severe fibrosis are prone to drug resistance because drugs are less likely to penetrate (Wu et al., 2025). Overall, such spatial differences make it clearer to see the complexity of the breast cancer microenvironment and also remind people that treatment should not be a one-size-fits-all approach. 8 Future Outlook and Conclusions Future spatial omics research seems to be increasingly "greedy" - not only looking at RNA, but also wanting to simultaneously observe protein, metabolic and even epigenetic information. Nowadays, some new spatial multi-omics techniques are attempting to detect multi-layer molecular signals on the same slice, making the picture of the tumor microenvironment more three-dimensional. Meanwhile, multimodal data at the single-cell level is also being "landed" in space. Researchers hope to remap information such as the transcriptome, epigenetics, and proteins to tissue locations to see exactly what the relationship is between gene regulation and spatial structure. When these data can truly be integrated, the cell networks and signal gradients in tumors may become clearer. Perhaps only then will precision oncology truly enter a stage where it can "see the details clearly". The value of spatial transcriptional modeling lies more in its ability to enable us to "see" the differences within tumors. In fact, each patient's tumor is different. In some areas, the immune system is active, while in others, it is almost silent. Piecing together these spatial features into a map is like drawing a map for the tumor. Doctors can determine from this which areas may respond well to immunotherapy and which areas, due to fibrosis or immune deficiency, may require other means of assistance. Spatial analysis does not end here. It can also help people identify the most aggressive or drug-resistant "danger zones", providing targets for radiotherapy or local medication. When these results are integrated with clinical data, perhaps a more individualized decision-making approach can be formed, making treatment no longer a one-size-fits-all approach but truly "tailored to local conditions". Overall, the modeling of spatial transcriptomics has provided us with a new way to observe the tumor microenvironment in more detail. As mentioned earlier in the article, this field has taken a considerable step forward, from spatial heterogeneity to data characteristics, and then to specific modeling methods and cases. But
RkJQdWJsaXNoZXIy MjQ4ODYzNA==